Clinical Trials Directory

Trials / Conditions / Recurrent Malignant Testicular Germ Cell Tumor

Recurrent Malignant Testicular Germ Cell Tumor

15 registered clinical trials studyying Recurrent Malignant Testicular Germ Cell Tumor.

StatusTrialSponsorPhase
TerminatedPalifosfamide in Treating Patients With Recurrent Germ Cell Tumors
NCT01808534
Indiana University School of MedicinePhase 2
WithdrawnMechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant
NCT01558778
Roswell Park Cancer InstituteN/A
CompletedSupersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or
NCT01305200
Children's Oncology GroupPhase 3
TerminatedDeferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload
NCT01159067
City of Hope Medical CenterPhase 2
CompletedPhase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer
NCT01037790
Abramson Cancer Center at Penn MedicinePhase 2
CompletedAlvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relaps
NCT00957905
National Cancer Institute (NCI)Phase 2
CompletedOndansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant
NCT00795769
Fred Hutchinson Cancer CenterPhase 2
CompletedCombination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors
NCT00467051
Children's Oncology GroupPhase 2
CompletedBusulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagn
NCT00638898
City of Hope Medical CenterPhase 1
CompletedHigh-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in T
NCT00536601
Roswell Park Cancer InstituteN/A
CompletedLithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem
NCT00408681
Fred Hutchinson Cancer CenterN/A
CompletedIpilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer
NCT00060372
National Cancer Institute (NCI)Phase 1
TerminatedImatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage II or Stage III Testic
NCT00042952
National Cancer Institute (NCI)Phase 2
CompletedVaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer
NCT00028496
National Cancer Institute (NCI)Phase 1
CompletedInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
NCT00004074
National Cancer Institute (NCI)Phase 1